Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of NPHP4 mRNA | increases expression | 16788091
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of NPHP4 mRNA | decreases expression | 15336504
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NPHP4 mRNA | affects cotreatment|increases expression | 17183730
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NPHP4 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NPHP4 mRNA | increases expression | 16788091
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NPHP4 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.95 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.87 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.25 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.32 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.42 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18775368 17507914 16609825 18396377 17688650 18558336 17157402 20603192 19232924 15238991 19460635 18316065 18940202 18985861 18177632 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.78 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
10.08 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
10.08 | 16197459 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.59 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.24 | 16443354 16873071 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.05 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.68 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.91 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.36 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.26 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.05 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.68 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.78 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.12 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.75 | 10589399 14991402 9211117 8800419 17551590 9125849 16925845 9664655 9224671 9142499 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.75 | 8888407 16575769 17688650 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.24 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.99 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.30 | 16569247 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.81 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.83 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.83 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.93 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.19 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.38 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.68 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.04 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 18467677 16221962 19176532 19772884 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.46 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.99 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.04 | 16612254 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.18 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.23 | 17551590 15992940 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.90 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.02 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
4.04 | 19850784 17596541 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.04 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.34 | 17301526 17506722 17368321 17712046 16766008 17107899 15748426 19075265 19642359 9834237 16331271 17339181 16935935 17294898 19035177 12679006 19225113 16823087 17217047 16788101 16140955 17361223 19029980 16891316 17649720 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.53 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.42 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.42 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.91 | 15890375 20007298 16377806 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.88 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.97 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.84 | 16940565 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18765137 18803445 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.93 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.93 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.36 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.36 | 16594593 16946489 |
OMIM:606966 |
NEPHRONOPHTHISIS 4 |
marker/mechanism |
|
| |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.16 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.95 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.95 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.42 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.16 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.55 | 15976015 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.29 | 20603192 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.95 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.26 | 16723453 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
12.06 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
12.06 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.94 | 14763951 17978042 11044598 15475178 3137016 11738929 1511512 16876388 |
MESH:C537581 |
Senior-Loken syndrome 4 |
marker/mechanism |
|
| |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
6.23 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.23 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.26 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.09 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.41 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.98 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.13 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.44 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.25 | 16287080 |